The Role of Split-course Hypofractionated Palliative Radiotherapy in Head and Neck Cancer

Abstract

Aims: A significant proportion of patients with head and neck squamous cell carcinoma are unsuitable for radical treatment due to factors including tumour stage, performance status and co-morbidity. Palliative radiotherapy has a useful role in the control of local symptoms. This study documented the outcome with split-course hypofractionated radiotherapy.